Watts R

ACER Integration, Somerset, UK.

8 papers

ArticlePsychedelics

As Psychedelic Treatments Get Leaner, Patients' Social Environments Deserve Attention.

Jacobs E, Roullier I, Watts R +1

Europe PMC2026
ArticlePsilocybin

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

Watts R, Kettner H, Geerts D +9

Europe PMC2022
ArticlePsilocybin

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Murphy R, Kettner H, Zeifman R +10

Europe PMC2021
ArticlePsilocybin

Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.

Timmermann C, Watts R, Dupuis D

Europe PMC2022
ArticlePsilocybin

Psychedelics and health behaviour change.

Teixeira PJ, Johnson MW, Timmermann C +5

Europe PMC2022
ArticlePsychedelics

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation.

Zeifman RJ, Wagner AC, Watts R +3

Europe PMC2020
ArticlePsychedelics

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health.

Gandy S, Forstmann M, Carhart-Harris RL +3

Europe PMC2020
ArticlePsilocybin

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ +13

Europe PMC2018